Hair Relaxer Lawsuit Settlement Amounts: There Isn't One Yet — Here's Where the Case Actually Stands
If you're searching for how much a hair relaxer lawsuit settlement pays, the honest answer is that no settlement has been reached, so there is no amount — average, typical or otherwise — to report. What does exist is a federal multidistrict litigation, MDL 3060, moving through a defined pretrial process in front of one judge. This page explains exactly where that process is, in plain language, so you know what's actually happened, what hasn't, and what would have to happen before anyone could honestly quote you a number.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Hair Relaxer Lawsuits Allege
The lawsuits consolidated into MDL 3060 allege a link between chemical hair relaxer and straightening products and the later diagnosis of uterine cancer in people who used them, typically over a period of years. Plaintiffs allege that manufacturers knew or should have known about this risk and failed to adequately warn users. These are allegations made in filed lawsuits — they have not been proven at trial, and no court has yet ruled on whether the scientific evidence behind them meets the legal bar required for a jury to hear it (see the Daubert process below). Nothing on this page should be read as a medical or legal conclusion about any individual product or case.
Case Details
In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation, MDL No. 3060, U.S. District Court for the Northern District of Illinois. Presiding judge: Mary M. Rowland.
Where the Case Stands Today
A large, active multidistrict litigation — with no settlement. As of August 2026, 11,877 lawsuits are pending in MDL 3060, up from 11,526 as of 1 May 2026. That growth tells you the litigation is still expanding, not winding down toward a resolution. There is no settlement fund, no claims administrator, no claim form and no deadline to file a claim, because there is nothing yet to claim against.
What has been happening is pretrial preparation aimed at a small number of test cases. Out of a pool of 32 potential bellwether cases, fact discovery — the phase where both sides gather documents, records and testimony — closed on 18 March 2026. From proposals submitted in April 2026, Judge Rowland selected the first three bellwether cases to move forward. Case-specific discovery in those three cases was scheduled to conclude by 10 June 2026.
Running in parallel, and arguably more consequential, is the fight over general causation — whether hair relaxer products can cause uterine cancer at all, as a matter of scientific evidence the court will allow a jury to hear. Expert discovery on that question closed on 2 March 2026, and the briefs arguing whether that expert evidence should be admitted (known as Daubert briefing) were due on 1 April 2026 and have been submitted. Judge Rowland has not yet ruled on them. That ruling — along with the separate Daubert and summary-judgment motions due on 16 November 2026 — is the actual bottleneck for everything that follows in this MDL.
Put simply: no bellwether trial has been held yet. First trials are generally expected in 2027, with late 2026 described as the earliest realistic possibility if the schedule moves faster than currently planned. Settlement talks in mass torts like this one typically follow bellwether verdicts, not precede them — both sides need to see how real juries respond to real evidence before either has a strong basis to negotiate a global number.
Who This May Eventually Involve
The people who filed the 11,877 lawsuits now pending in MDL 3060 generally allege that they used chemical hair relaxer or straightening products and were later diagnosed with uterine cancer. Whether any individual set of facts would ultimately support a claim — and what it might be worth — depends on evidence that hasn't been tested in court yet, because no bellwether trial has taken place and the general-causation Daubert ruling that would shape those trials hasn't been issued.
That doesn't mean there's nothing to do. It means the useful steps right now are different from what they'll be once trials start producing outcomes:
- Preserve your records. Product purchase history, receipts, salon records, and — most importantly — complete medical records around a uterine cancer diagnosis are what any eventual claim, in or out of a settlement, will depend on. These get harder to reconstruct the longer you wait.
- A lawsuit can still be filed even though there's no settlement. Filing an individual lawsuit that becomes part of MDL 3060 is a separate step from filing a claim in a settlement — the former is available now (subject to your state's statute of limitations, which this page does not attempt to state, since it varies by state and by when the injury was discovered); the latter doesn't exist yet because there's no settlement to file into.
- Don't take a number from anyone right now as anything other than a guess. No dollar figure — average, typical, minimum or maximum — can honestly be attached to a hair relaxer claim while general causation hasn't been ruled on and no bellwether verdict exists.
Why There Is No Settlement Amount to Report
There is no average hair relaxer lawsuit settlement, no typical payout, and no range — high, low, or otherwise — because no settlement has been reached. Any number you see attached to this litigation right now is not describing something that has happened; it's describing something someone is guessing about, extrapolating from other, unrelated mass torts, or simply inventing to get you to respond.
To understand why a number doesn't exist yet, it helps to understand two things this case is currently waiting on:
What a bellwether trial is. In a multidistrict litigation with thousands of individual lawsuits, courts don't try every case one at a time. Instead, a small number of representative cases — here, three, selected by Judge Rowland from a larger pool of 32 candidates — are prepared and tried first. How those bellwether trials turn out (who wins, and if a plaintiff wins, what a jury awards) gives both sides real information about how similar cases might fare, which is usually what pushes settlement negotiations forward. Until at least one bellwether trial happens, there's no verdict for either side to react to.
What a Daubert ruling is, and why it matters here specifically. Before a jury can hear expert testimony on a scientific question — in this case, whether hair relaxer products can cause uterine cancer at all — a judge has to decide whether that expert testimony is reliable enough to be admitted. This is called a Daubert ruling, after the U.S. Supreme Court case that set the standard. In MDL 3060, the briefing on general causation is done, but Judge Rowland has not yet ruled. Until she does, it isn't settled whether juries in this MDL will even be allowed to hear the core scientific argument behind these lawsuits — which is why no bellwether trial can meaningfully proceed yet, and why 16 November 2026 (the deadline for further Daubert and summary-judgment motions) is a real date to watch rather than a settlement date.
Once a general-causation ruling is issued and bellwether trials actually produce verdicts — expected generally in 2027 — there will be real information to base a number on. Right now, there isn't.
How the Case Has Developed
- 1
2 March 2026 — General-causation expert discovery closes
Discovery on the core scientific question — whether hair relaxer products can cause uterine cancer — closes, clearing the way for both sides to argue over whether that expert evidence should be admitted at trial.
- 2
18 March 2026 — Fact discovery closes in the 32-case bellwether pool
Document and testimony gathering concludes across the larger pool of candidate bellwether cases from which the first trial cases will be selected.
- 3
1 April 2026 — General-causation Daubert briefs submitted
Both sides file their briefs arguing whether expert testimony on general causation meets the legal standard for admission. Judge Rowland's ruling on these briefs has not yet been issued and is the current bottleneck for the bellwether schedule.
- 4
April 2026 — Judge Rowland selects the first three bellwether cases
From proposals submitted that month, Judge Rowland chooses the first three cases out of the 32-case pool to proceed toward trial as bellwethers.
- 5
10 June 2026 — Case-specific discovery in the three bellwether cases set to close
Discovery focused specifically on the facts of the three selected bellwether cases was scheduled to conclude, moving those cases closer to trial-ready status.
- 6
August 2026 — Pending case count reaches 11,877
The number of lawsuits consolidated in MDL 3060 grows to 11,877, up from 11,526 as of 1 May 2026 — evidence the litigation is still expanding rather than approaching resolution.
- 7
16 November 2026 — Daubert and summary-judgment motions due
The next scheduled milestone in the case. These motions, and any rulings that follow, will shape whether and how the bellwether cases proceed toward the trials generally expected in 2027 (with late 2026 possible only if the schedule accelerates).
What to Be Careful About
A large, actively growing MDL with a serious health allegation attached is exactly the kind of case that draws people offering a settlement process that doesn't exist yet. These are the specific patterns to watch for.
"Sign up now for the hair relaxer settlement"
There is no hair relaxer lawsuit settlement to sign up for. MDL 3060 has not produced a settlement, a bellwether verdict, or even a ruling on whether the core scientific evidence will be admitted. Anyone advertising a settlement registration, claim form or payout program for this litigation right now is describing something that has not happened.
Any specific dollar amount — average, typical, minimum or maximum
No verdict has been reached in any hair relaxer bellwether case, and no settlement has been negotiated. A number presented as an average or typical settlement amount for this litigation is not based on anything that has actually occurred in the case — it cannot be, since nothing has been paid out and no jury has ruled.
Urgency built around a deadline that isn't real
There is no bar date, no settlement filing deadline, and no administrator-imposed cutoff for this litigation, because there is no settlement or trust for one to belong to. Pressure to "act before it's too late" to join a hair relaxer settlement is describing a deadline that, as of this litigation's current status, does not exist — separate and apart from your state's own statute of limitations for filing a lawsuit in the first place, which is a real legal deadline but a different thing entirely and varies by state.
Common Questions
Is there a hair relaxer lawsuit settlement yet?
No. As of August 2026, MDL 3060 has not reached a settlement. There is no settlement fund, no claims administrator, no claim form, and no average or typical settlement amount to report, because none has been negotiated or paid.
What is MDL 3060?
MDL 3060 — In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation — is the federal multidistrict litigation consolidating lawsuits that allege a link between chemical hair relaxer products and uterine cancer. It is being handled by Judge Mary M. Rowland in the U.S. District Court for the Northern District of Illinois.
How many hair relaxer lawsuits are there right now?
As of August 2026, 11,877 lawsuits are pending in MDL 3060, up from 11,526 as of 1 May 2026. The number has been growing, which is one reason it's too early to talk about a settlement — the full scope of the litigation isn't settled yet either.
What is a bellwether trial, and why does it matter here?
A bellwether trial is one of a small number of representative cases selected out of a much larger group of lawsuits in an MDL and tried first. Judge Rowland has selected the first three bellwether cases from a pool of 32 candidates. How those trials turn out gives both sides real evidence about how a jury responds to the claims, which is typically what moves settlement negotiations forward in a mass tort. No bellwether trial in MDL 3060 has happened yet.
What is a Daubert ruling, and why is it the current bottleneck?
A Daubert ruling is a judge's decision on whether expert scientific testimony is reliable enough to be presented to a jury. In MDL 3060, both sides have submitted briefing on whether expert testimony that hair relaxer products can cause uterine cancer meets that standard, but Judge Rowland has not yet ruled. Until she does, it isn't settled whether juries in this MDL can even hear that core scientific argument — which is why bellwether trials haven't meaningfully proceeded and why a further round of Daubert and summary-judgment motions is due on 16 November 2026.
When will hair relaxer lawsuit settlements actually happen?
There's no published date. First trials in MDL 3060 are generally expected in 2027, with late 2026 described as the earliest realistic possibility if the current schedule accelerates. Settlement negotiations in litigation like this typically follow bellwether trial verdicts rather than precede them, so a settlement — if one is eventually reached — would likely come after trials have actually taken place.
Should I do anything now if I used a hair relaxer product and was diagnosed with uterine cancer?
There's no settlement claim to file yet, but preserving your records now matters regardless of when or whether one happens: product purchase or usage history and complete medical records around your diagnosis are what any eventual claim would depend on. Filing an individual lawsuit — which becomes part of MDL 3060 — is a separate, currently available step from filing into a settlement, and is subject to your state's own statute of limitations, which this page doesn't attempt to state since it varies by state.
What happens after the November 2026 Daubert and summary-judgment rulings?
Those rulings, along with the still-pending decision on the earlier general-causation Daubert briefing, will determine what evidence can actually go in front of a jury and which claims survive to trial. That in turn shapes whether and when the selected bellwether cases go to trial — which is what first trials generally expected in 2027 depend on.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.